Comparison

TRIM23 Antibody (N-term) Blocking peptide

Item no. ABC-BP13641a
Manufacturer Abcepta
Amount 500 ug
Category
Type Peptides
Format Lyophilized
Specific against other
Citations Arimoto, K., et al. Proc. Natl. Acad. Sci. U.S.A. 107(36):15856-15861(2010)Poole, E., et al. J. Virol. 83(8):3581-3590(2009)Venkatesan, K., et al. Nat. Methods 6(1):83-90(2009)Vichi, A., et al. Proc. Natl. Acad. Sci. U.S.A. 102(6):1945-1950(2005)Reymond, A., et al. EMBO J. 20(9):2140-2151(2001)
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias E3 ubiquitin-protein ligase TRIM23,632-,ADP-ribosylation factor domain-containing protein 1,GTP-binding protein ARD-1,RING finger protein 46,Tripartite motif-containing protein 23,TRIM23,ARD1,ARFD1,RNF46
Similar products TRIM23, ARD1, ARFD1, RNF46, E3 ubiquitin-protein ligase TRIM23, ADP-ribosylation factor domain-containing protein 1, GTP-binding protein ARD-1, RING finger protein 46, Tripartite motif-containing protein 23, 632-
Available
Manufacturer - Category
Peptides; Blocking Peptides
Manufacturer - Targets
The synthetic peptide sequence used to generate the antibody AP13641a was selected from the N-term region of TRIM23. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Bio Background
The protein encoded by this gene is a member of thetripartite motif (TRIM) family. The TRIM motif includes threezinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. This protein is also a member of the ADPribosylation factor family of guanine nucleotide-binding family ofproteins. Its carboxy terminus contains an ADP-ribosylation factordomain and a guanine nucleotide binding site, while the aminoterminus contains a GTPase activating protein domain which acts onthe guanine nucleotide binding site. The protein localizes tolysosomes and the Golgi apparatus. It plays a role in the formationof intracellular transport vesicles, their movement from onecompartment to another, and phopholipase D activation. Threealternatively spliced transcript variants for this gene have beendescribed.
Gene Name
TRIM23
Subtitle
Synthetic peptide
Formulation
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close